Worth Financial Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,767
Closed -$201K 162
2024
Q3
$201K Buy
1,767
+90
+5% +$10.7K 0.12% 162
2024
Q2
$208K Buy
+1,677
New +$216K 0.14% 141
2023
Q2
Sell
-3,684
Closed -$392K 123
2023
Q1
$392K Buy
3,684
+837
+29% +$90.4K 0.37% 73
2022
Q4
$316K Buy
+2,847
New +$291K 0.37% 73

Other funds holding MRK

Worth Financial Advisory Group's MRK Position: Q4 2024 in Review

Worth Financial Advisory Group sold out of Merck (MRK) in Q4 2024, closing a stake of 1,767 shares — an estimated $201K sold.

Worth Financial Advisory Group first reported a position in MRK in Q4 2022 and held it in 4 quarters. The position peaked at $392K in Q1 2023. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Worth Financial Advisory Group reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Worth Financial Advisory Group sold 1,767 Merck shares in Q4 2024, an estimated $201K.
  • Worth Financial Advisory Group first reported a position in Merck in Q4 2022 and held it in 4 quarters.
  • Worth Financial Advisory Group's Merck position peaked at $392K in Q1 2023.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Worth Financial Advisory Group's 13F filing for Q4 2024, filed 12 Feb 2025.